论文部分内容阅读
[目的]评价在硬膜外阻滞下行肝动脉栓塞化疗的可行性和安全性。[方法]68例肝恶性肿瘤患者随机分为A组35例在硬膜外阻滞下肝动脉栓塞化疗,B组33例行常规肝动脉栓塞化疗。观察两组术中疼痛反应情况、手术时间和射线辐射时间。[结果]A组采用硬膜外阻滞下行肝动脉栓塞化疗术中腹痛不适发生率14.3%(5/35)明显低于常规肝动脉栓塞化疗组75.8%(25/33)(P<0.05),而且手术时间减少和射线辐射时间缩短。[结论]硬膜外阻滞下行肝动脉栓塞化疗能减轻患者术中腹痛等不适,减少手术时间,降低射线辐射量,是安全、可行的。
[Objective] To evaluate the feasibility and safety of transcatheter arterial chemoembolization in epidural blockade. [Method] Sixty-eight patients with hepatic malignancy were randomly divided into group A (n = 35) undergoing epidural blockade of hepatic arterial chemoembolization and group B (n = 33) under conventional hepatic arterial chemoembolization. Two groups of intraoperative pain response, operation time and radiation time were observed. [Results] The incidence of abdominal pain discomfort in group A with epidural blockade was 14.3% (5/35), which was significantly lower than that in conventional hepatic arterial chemoembolization group (75.8%, P <0.05) , But also reduce the operation time and radiation irradiation time shortened. [Conclusion] Down-pump transcatheter arterial chemoembolization with epidural blockade can reduce abdominal pain and other discomfort during operation, reduce operation time and reduce radiation dose, which is safe and feasible.